Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women (MIP)

This study seeks to understand the immune cells in the cervical fluid of in the blood and genital tract of HIV-negative healthy female volunteers and to see if these cells can be modified using a combined anti-viral and antiinflammatory drug called maraviroc, a medicine used in the treatment of HIV infection.

*Study was terminated as minimal efficacy of maraviroc alone was found in preliminary data analysis of another study*